Search clinical trials for: semapimod

Total 6 results

Ferring Pharmaceuticals

Terminated

CNI-1493 for Treatment of Moderate to Severe Crohn's Disease (CD02)

Crohn Disease

United States
Ferring Pharmaceuticals

Completed

Single Ascending Dose Study of Oral CPSI-2364 (Semapimod)

Crohn's Disease

United States
Kinarus AG

Suspended

The KIN-FAST Trial (KIN001 For Accelerated Symptoms Termination) in Non Hospitalized Patients Infected With SARS-CoV-2 (KIN-FAST)

COVID-19

Switzerland, Germany
Ferring Pharmaceuticals

Completed

Extension Study of Semapimod 60 mg IV x 3 Days (CD06)

Crohn's Disease

United States, Netherlands, Israel, Germany
Ferring Pharmaceuticals

Completed

Long-term Study of Semapimod (CNI-1493) for Treatment of Crohn's Disease (CD05)

Crohn's Disease

United States, Netherlands, Israel, Belgium, Germany
Ferring Pharmaceuticals

Completed

Semapimod for Treatment of Moderate to Severe Crohn's Disease 1 or 3 Days' Treatment Versus Placebo (CD04)

Crohn's Disease

United States, Netherlands, Israel, Belgium, Germany

3

Subscribe